![]() |
市場調查報告書
商品編碼
1874464
枸橼酸馬羅匹坦:全球市場佔有率和排名、總收入和需求預測(2025-2031年)Maropitant Citrate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024 年全球枸橼酸馬羅匹坦市場規模估計為 4.37 億美元,預計到 2031 年將達到 7.01 億美元,2025 年至 2031 年的複合年成長率為 6.7%。
本報告對近期關稅調整和國際戰略反制措施對枸橼酸馬羅匹坦的跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。
枸橼酸馬羅匹坦是動物用藥品,主要用於預防和治療犬貓的噁心和嘔吐。它是一種神經肽1 (NK1) 受體拮抗劑,可抑制神經肽P(一種參與嘔吐反射的主要神經傳導物質)的作用。該藥有口服藥片和注射兩種劑型,廣泛用於治療暈動病、胃腸炎和化療引起的嘔吐等疾病。
枸橼酸馬羅匹坦現已成為全球動物用藥品市場廣泛認可的止吐藥。隨著寵物主人數量的增加、寵物醫療保健的擴展以及動物福利意識的提高,對高效安全動物用藥品的需求持續成長。枸橼酸馬羅匹坦可有效治療犬貓因胃腸道疾病、化療和麻醉引起的嘔吐,並已成為獸醫診所的標準治療方法。在北美、歐洲和日本等成熟市場,枸橼酸馬羅匹坦擁有極高的使用率、強大的品牌忠誠度以及獸醫專業人士對其臨床應用的信賴。
展望未來,枸橼酸馬羅匹坦市場正變得日益專業化和分散化。動物用藥品法規結構迫使生產商滿足更高的安全性、穩定性和品質標準,從而推動了對符合GMP認證的生產和製劑創新方面的投資。同時,市場對更方便飼主且更具針對性的劑型(例如速溶口服片劑和緩釋性注射劑)的需求也在不斷成長,這些劑型能夠靈活適應不同體型、疾病狀況和主人偏好的寵物。此外,中國、巴西和東南亞等新興市場寵物飼養的日益普及,也為基於馬羅匹坦的治療方法帶來了巨大的新成長機會。
儘管存在這些積極趨勢,但該行業仍面臨許多挑戰。關鍵專利的到期導致學名藥湧入市場,加劇了價格競爭,並侵蝕了品牌藥的市場佔有率。此外,原物料價格波動、全球物流中斷以及各地藥品註冊政策的差異,都使供應鏈管理和國際市場擴張變得更加複雜。另一個挑戰在於終端使用者的行為。許多寵物飼主不了解這些藥物的正確使用方法和潛在副作用,導致用藥依從性差。因此,製造商不僅必須確保產品品質和療效的穩定性,還必須投資於市場教育、獸醫合作以及在地化行銷策略,以創造價值並保持競爭優勢。
本報告旨在依地區/國家、類型和應用對全球枸橼酸馬羅匹坦市場進行全面分析,重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。
本報告以2024年為基準年,以銷量(千)和收入(百萬美元)為單位,對枸橼酸馬羅匹坦的市場規模、估算和預測進行了呈現,並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定枸橼酸馬羅匹坦的業務和成長策略,評估市場競爭,分析自身在當前市場中的地位,並做出明智的商業決策。
市場區隔
公司
依類型分類的區隔市場
應用領域
依地區
The global market for Maropitant Citrate was estimated to be worth US$ 437 million in 2024 and is forecast to a readjusted size of US$ 701 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Maropitant Citrate cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Maropitant citrate is a veterinary medication primarily used to prevent and treat nausea and vomiting in dogs and cats. It is a neurokinin-1 (NK1) receptor antagonist, which works by blocking the action of substance P, a key neurotransmitter involved in the vomiting reflex.Available in tablet form for oral administration and as an injectable solution, maropitant is commonly used for conditions such as motion sickness, gastroenteritis, and chemotherapy-induced vomiting.
At present, Maropitant Citrate has become a widely recognized antiemetic agent in the global veterinary pharmaceutical market. As pet ownership rises, along with growing expenditure on pet healthcare and increasing awareness of animal welfare, the demand for effective and safe veterinary drugs continues to expand. Maropitant Citrate, known for its efficacy in managing vomiting caused by gastrointestinal disorders, chemotherapy, or anesthesia in dogs and cats, has become a standard treatment in veterinary clinics. In mature markets such as North America, Europe, and Japan, the drug enjoys high usage rates, strong brand loyalty, and established clinical dependence among veterinary professionals.
Looking forward, the Maropitant Citrate market is expected to trend toward greater specialization and segmentation. As veterinary drug regulatory frameworks become more stringent, manufacturers are under pressure to comply with higher safety, stability, and quality standards, driving investments in GMP-certified production and formulation innovation. In parallel, there is increasing demand for more user-friendly and targeted dosage forms-such as fast-dissolving oral tablets or extended-release injectables-that can better accommodate varying pet sizes, medical conditions, and owner preferences. Furthermore, the rising pet adoption rates in emerging markets, including China, Brazil, and Southeast Asia, are opening up significant new growth opportunities for Maropitant-based therapies.
Despite these favorable trends, the industry faces several headwinds. The expiration of key patents has led to the entry of generic versions, intensifying price competition and eroding the market share of originator brands. Additionally, raw material price fluctuations, disruptions in global logistics, and variations in regional drug registration policies complicate supply chain management and international market expansion. Another challenge lies in end-user behavior-many pet owners remain unaware of the proper use and potential side effects of such medications, resulting in inconsistent compliance. Therefore, beyond ensuring consistent product quality and therapeutic effectiveness, manufacturers must also invest in market education, veterinary engagement, and localized marketing strategies to sustain value creation and competitive advantage.
This report aims to provide a comprehensive presentation of the global market for Maropitant Citrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Maropitant Citrate by region & country, by Type, and by Application.
The Maropitant Citrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maropitant Citrate.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Maropitant Citrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Maropitant Citrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Maropitant Citrate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.